Chronic thromboembolic pulmonary hypertension (CTEPH)

Heart

Volumn 93, Issue 9, 2007, Pages 1152-1158

  McNeil, Keith ^a   Dunning, John ^a,b  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; COLLAGEN; HEMOSIDERIN; ILOPROST; PROSTACYCLIN; WARFARIN;

AORTA ARCH SYNDROME; ATHEROSCLEROSIS; CHRONIC DISEASE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; DIAGNOSTIC PROCEDURE; HUMAN; IMAGING SYSTEM; MEDIASTINITIS; PATHOGENESIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SARCOMA; VASCULAR DISEASE;

CHRONIC DISEASE; ENDARTERECTOMY; HUMANS; HYPERTENSION, PULMONARY; MAGNETIC RESONANCE ANGIOGRAPHY; PULMONARY ARTERY; THROMBOEMBOLISM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34548183278     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.053603     Document Type: Review

References (20)

1. Riedel M, Stanek V, Widimsky J, et al. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 1982;81:151-8. ▶ Pivotal study defining the prognosis of CTEPH according to severity of underlying pulmonary hypertension.
2. Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350:2257-64. ▶ One of very few studies defining the natural history of acute pulmonary embolism and its relationship to the development of CTEPH.
3. Rubin LJ. Diagnosis and management of pulmonary arterial hypertension: ACCP Evidence-Based Clinical Practice Guidelines. Chest 2004;126:7S-10S.
4. Hoeper MM, Mayer E, Simonneau G, et al. Chronic thromboembolic pulmonary hypertension. Circulation 2006;113:2011- 20. ▶ Recent comprehensive review of CTEPH from both a European and North American perspective.
5. Auger WR, Kim KM, Kim NH, et al. Chronic thromboembolic pulmonary hypertension. Cardiol Clin 2004;22:453-66. ▶ Comprehensive review of CTEPH from the centre with the largest experience in the world of the assessment and surgical (PEA) treatment of patients with CTEPH.
6. Thistlethwaite PA, Jamieson SW. Pulmonary thromboendarterectomy. Ann Thorac Surg 2004;78:746-7.
7. Remy-Jardin M, Louvegny S, Remy J, et al. Acute central thromboembolic disease: post therapeutic follow-up with spiral CT angiography. Radiology 1997;203:173-80.
8. Ribeiro A, Lindmarker P, Johnsson H, et al. Pulmonary embolism. One-year follow-up with echocardiography Doppler and five-year survival analysis. Circulation 1999;99:1280-3.
9. Wartski M, Collignon MA. Incomplete recovery of lung perfusion after 3 months in patients with acute pulmonary embolism treated with antithrombotic agents. J Nucl Med 2000;41:1043-8.
10. McNeil K, Dunning J, Morrell N. The pulmonary physician in critical care. 13: the pulmonary circulation and right ventricular failure in the ITU. Thorax 2003;58:157-62.
11. Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 1993;103:685-92. ▶ The original article describing the secondary small vessel arteriopathy and its role in CTEPH. Remains the definitive opinion today.
12. Olman MA, Marsh JJ, Lang IM, et al. Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension. Circulation 1992;86:1241-8.
13. Blauwet LA, Edwards WD, Tazelaar HD, et al. Surgical pathology of pulmonary thromboendarterectomy: a study of 54 cases from 1990 to 2001. Hum Pathol 2003;34:1290-8. ▶ Excellent description of the surgical pathology of PEA and its correlation with some aspects of clinical presentation and natural history of CTEPH.
14. Bonderman D, Turecek PL, Jakowitsch J, et al. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost 2003;90:372-6. ▶ Report of the first coagulation abnormality identified in a large proportion of patients with CTEPH.
15. Lang IM, Marsh JJ, Mitchell AO, et al. Parallel analysis of tissue-type plasminogen activator and type 1 plasminogen activator inhibitor in plasma and endothelial cells derived from patients with chronic pulmonary thromboemboli. Circulation 1994;90:706-12.
16. Kim N, Fesler P, Channick RN, et al. Preoperative partitioning of pulmonary vascular resistance correlated with early outcome after thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Circulation 2004;109:18-22. ▶ Reports the value of this technique in identification of small vessel arteriopathy, which has the potential to identify those patients at greatest risk of mortality and morbidity post-PEA.
17. Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 2003;76:1457-62; discussion 1462-4. ▶ A report of the largest single centre experience of PEA, and the definitive opinion on the subject.
18. Mares P, Gilbert T, Tscherno EM, et al. Pulmonary artery thromboendarterectomy: a comparison of two different postoperative treatment strategies. Anesth Analg 2000;90:267-73.
19. Hagl C, Khaladj N, Peters T, et al. Technical advances of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Eur J Cardiothorac Surg 2003;23:776-81.
20. Hughes R, George P, Parameshwar J, et al. Bosentan improves inoperable chronic thromboembolic pulmonary hypertension. Eur Respir J 2006;28:138-43. ▶ This report highlights the increasing interest in, and efficacy of, PAH specific drug treatment in patients with inoperable CTEPH.